Skip to main content
. 2021 Mar 2;11(3):421. doi: 10.3390/diagnostics11030421

Table 5.

Clinical trials that investigated the diagnostic value of circulating miRNAs in lung cancer. Clinical trials registered at the US National Institutes of Health database (ClinicalTrials.gov) using the keywords “miRNA and lung cancer” (search results from 12 January 2021).

Title of Study Status Completion Date Enrollment Analysis Study Results Pre-Clinical References
Plasma microRNA Profiling as First Line Screening Test for Lung Cancer Detection: A Prospective Study Active, not recruiting September 2021 4119 participants (healthy heavy smokers) Pre-selected panel of 24 miRNAs in plasma Study not completed [31,114,115]
Addition of microRNA Blood Test to Lung Cancer Screening Low Dose CT Active, not recruiting August 30, 2020 479 participants undergoing LDCT (smokers) Hummingbird Diagnostic´s microRNA test for lung cancer diagnosis in total blood No results available Not provided
MicroRNA Genetic Signature in NSCLC Egyptian Patients Completed August 2016 40 participants (20 NSCLC, 10 nonsmokers, 10 smokers) miRNA signature pattern in NSCLC Egyptian patients (by microarray) No results available Not provided
Quantification of microRNAs in Diagnosis of Pulmonary Nodules Completed May 2019 103 participants (patients with nodules >5 mm and <30 mm in the lung parenchyma) Pre-selected panel of 34 miRNAs No results available Not provided
Plasma miRNAs Predict Radiosensitivity of Different Fractionation Regimes in Palliative Radiotherapy for Advanced Non-small Cell Lung Cancer: Multicenter Controlled Study (RadimiR-01) Unknown Last update posted: March 2017 Estimated 240 participants (NSCLC) Unspecified miRNAs in plasma No results available Not provided
Association between VEGF-C and miRNA and Clinical Non-small Cell Lung Cancer and Esophagus Squamous Cell Carcinoma Unknown Last update posted: Nov 2010 Estimated 250 participants (NSCLC) Unspecified miRNAs in unspecifies biological samples, probably serum No results available Not provided

LDCT: low-dose computed tomography; NSCLC: non-small-cell lung cancer; Study has passed its completion date, and status has not been verified in more than two years.